| INTRODUCTION

Capillary electrophoresis (CE) was first introduced in 1980s
and has emerged as a powerful separation technique which is competitive/complimentary to HPLC. 1 It is a versatile technique with low maintenance cost and hence suitable for routine clinical laboratories. Its applications in clinical laboratory vary from tests such as protein separation, determination of hemoglobin variants, and classification of gammopathies 2 to detect carbohydrate-deficient transferrin in alcohol abusers.
3,4
Carbohydrate-deficient transferrin (CDT) collectively refers to the desialylated transferrin isoforms. These isoforms lack sialic acid residues and are deficient in their oligosaccharide chain. 5 Transferrin (Tf) is an abundant serum glycoprotein with two N-linked disialylated biantennary oligosaccharide chains thus most Tf is in tetrasialo form followed by other minor isoforms which vary depending on the number of oligosaccharide chains. 6 Hyposialylation or desialylation of transferrin produces altered isoform pattern which is a diagnostic marker for alcohol abuse. 5, 7 Patterns similar to these also occur in other secondary glycosylation defects like fructosemia and galactosemia 8 and primary defects i.e. Congenital Disorders of Glycosylation (CDG).
9
CDG are a group of <40 disorders with multisystemic clinical spectrum ranging from severe mental retardation with dysmorphic features or mild retardation to being asymptomatic in some cases. 10 Symptoms observed are highly variable, however, a few common presenting features include hypotonia, skin manifestations, cutix laxa, coagulopathies, inverted nipples, cerebellar atrophy, and hypoplasia etc. These patients show global developmental delay (GDD) often with or without neurological involvement. 11, 12 These features are overlapping with several non-genetic conditions and hence screening for CDG would assist in all unexplained conditions. Transferrin being the most abundant well-characterized glycoprotein, its isoform analysis is used as an initial test to rule out CDG. 
| MATERIALS AND METHODS
Present study on method verification and comparison for transferrin isoforms was carried out in biochemistry section of the institute and was approved by the Institutional review board. Serum and plasma samples were collected from 30 (four males & 26 females) non-alcoholic healthy individuals for assessment of CDT kit and obtaining the isoform range in them. To detect its efficacy to identify the altered isoform pattern in CDG, blood samples were obtained from 50 patients clinically suspected to have CDG. The samples were stored at −20°C immediately after separation, and were analyzed within 6-8 weeks. Hemolysis interferes with the separation and hence hemolyzed samples were not included in the study. All the 80 samples (30 controls and 50 patients) were also analyzed usingthe in-house developed HPLC method for separation of transferrin isoforms. 
| Chemicals
| Analysis on CE
Analysis was carried out with a MINICAP electrophoresis system (Sebia) with an ultraviolet absorbance detector at 200 nm wavelength.
The buffer system of the MINICAP CDT method was used for the initial activation of capillaries. It is an automated system with in line dilution and processing of samples. Samples were injected at the anodic end followed by an 8 minute separation and detection at 200 nm.
Isoform peaks were auto-identified & AUCs were calculated with the 'Phoresis' software.
| Method evaluation
Normal and pathological controls provided in the kit were analyzed in duplicates with each batch. Precision and reproducibility was assured by auto-integration of each isoform by the software. 
| Analysis on HPLC
Transferrin isoforms were separated and detected using ion-exchange chromatography as described by Quintana et al. 6 Before separation on HPLC, plasma transferrin was iron saturated with Fe 3+ and was treated with Calcium chloride-Dextran sulfate mixture for the removal of lipids. The isoforms were then separated using SOURCE 15Q PE 4.6/100 anion exchange column from GE Healthcare. The separation was achieved by salt gradient elution at 40ºC followed by isoform detection at 470 nm.
Transferrin calibrator of 273 mg/dL concentration from the transferrin estimation kit of BECKMAN IMMAGE system (kit no 449560)
and a healthy control sample were processed for isoform separation and peak identification. A healthy control's sample was then incubated at 37°C with 0.2 U/L of neuraminidase. The incubation was done for varying time points to ensure desialylation of transferrin so as to mimic isoform pattern observed in CDG patients. The separation of these isoforms was then performed on HPLC for detection of asialylated isoforms. For intra-day and inter-day precision, an aliquot of pooled serum of healthy control samples was analyzed with every batch.
| Verification of test results
The test results for three healthy controls & two CDG-suspected patients were also verified by established methods for CDG diagnosis like IEF and MALDI TOF. 
| Statistical analysis for method comparison
Transferrin isoform patterns for healthy controls and patients sus- 
| RESULTS
| Isoform detection on capillary electrophoresis
The kit controls showed well-differentiated isoform fractions with a predominant tetrasialo transferrin peak in normal control and welldifferentiated minor fractions of desialylated isoforms in pathological controls. The isoform pattern of a healthy individual and pathological control is shown in Figure 1 . Auto-integration of the peaks by Phoresis software was obtained for the samples assuring precision and reproducibility of the CDT kit. The % AUC of each isoform fraction in both the controls was within the defined range and showed an intra-day & inter-day %CV of <20 for major isoforms (Table 1) .
Normal control did not show any alteration in transferrin profile when injected after a pathological control suggesting no or insignificant carryover. Sensitivity of the CE system to detect isoforms by the software was obtained to be ≤0.6% of total transferrin. The isoform fractions in 30 healthy individuals were comparable with the reference ranges reported in literature 3 ( Table 2 ). Of the 50 suspected patients, 96% of patients showed a normal isoform pattern thus ruling out N-glycosylation defects. Two patients had an abnormal pattern suggestive of CDG. One patient showed an increase in disialotransferrin while the second patient had an increase of both disialotransferrin and asialotransferrin. There was a proportionate decrease in tetrasialo transferrin in both these patients ( Figure 2 ). 
| Isoform detection on HPLC
Transferrin calibrator and healthy controls showed well-differentiated isoform fractions with predominant tetrasialo transferrin peak followed by pentasialo, trisialo, and disialotransferrin peaks (Figure 3.1) . In vitro desialylation of healthy control plasma with neuraminidase over different time points showed a gradual increase in asialylated transferrin isoforms with a proportional decrease of tetrasialo transferrin (Figure 3 .2).
The % AUC for each isoform fraction of pooled control plasma
showed an intra-day and inter-day %CV of <20. The isoform pattern of all the 30 healthy controls and clinically suspected patients showed comparable results with CE (Table 3) . Abnormal isoform pattern obtained in CE showed similar results with HPLC ( Figure 4 ). 
| Verification of results
| Statistical comparison
The Figure 5 ).
| DISCUSSION
Transferrin, an abundant glycoprotein exhibits microhetrogeneity because of variable sialic acid residues attached to its glycan chains. 24 Among the various isoforms, tetrasialotransferrin is the most predominant isoform followed by penta, tri, and disialotransferrin. Glycosylation defects both primary and secondary result in an altered isoform pattern which is used for diagnosis. Several separation methods such as IEF, HPLC, and CE & mass spectrometry have been used for the detection of isoforms. IEF has been abundantly used since 1980s. However, it has several limitations such as being labor intensive with subjective interpretation 5 and is also expensive because of the anti-sera and stains used for analysis.
Capillary electrophoresis performs separation of isoforms at high voltage based on electric charge and molecular mass. For Tf separation on CE, latest migrating isoform presents the most negative electric charge which is attributable to the number of sialic acid residues. 4 In the present study, we have verified the performance of CDT kit on CE.
This closed system analyzes samples directly unlike HPLC where samples are treated manually for iron saturation and delipidification. This reduces manual errors and time required for sample pre-treatment.
The reproducibility and reliability of the method was qualified by obtaining <20% AUC for major isoforms of the kit controls. However, for asialotransferrin %CV for AUC was 31.5. This may have been because of the minor proportion of this fraction in the pathological control.
A similar increase in %CV for minor isoforms has been reported in HPLC. 6 There was a minimal variation in the AUC of the normal controls analyzed alternating to the pathological control ensuring minimal carry over.
Our HPLC method was optimized to detect all isoforms. This was confirmed by neuraminidase treatment where in the presence of desialylated isoforms was directly proportional to the incubation time with neuraminidase. A similar neuraminidase-treated transferrin isoform variation has also been reported by Helander et al. 25 The isoforms showed a <20% CV for AUC of each isoform in pooled plasma except for disialotransferrin which had a %CV of 21.5. This may be because of the minor proportion of this isoform. Quintana et al. 6 have also reported a %CV of 21.8 for disialotransferrin. However, for CE our %CV for disialotransferrin is 8.3 & 11.9 for intra-day and inter-day, respectively, suggesting the reproducibility of CE even for minor isoforms.
The CE results were comparable with our in-house developed HPLC-based assay wherein both healthy controls and the CDGsuspected patients showed similar results. The variation between AUC of all the isoforms by both methods was statistically non-significant.
In IEF, the isoelectric point of transferrin is determined by its glycosylation status while MALDI TOF assesses the extent of glycosylation of transferrin depending on the number of glycan chains present on the with corneal clouding while patient B with a six-fold increase in disialotransferrin presented with GDD, inverted nipples, broad base gait and up-slant eyes.
To the best of our knowledge, these are the first cases of CDG detected and reported from India. One case of Indian origin has been reported by Newell et al. 26 In our small study group of 50 patients, In our patients, we did not get an increase in monosialo transferrin.
Interference of C3 fractions particularly in the samples stored at room temperature have been reported. 29 To avoid this degradation and in- 
